RPG Life Sciences (NSE:RPGLIFE) Cash-to-Debt : No Debt ⁽¹⁾ (As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. RPG Life Sciences's cash to debt ratio for the quarter that ended in Sep. 2024 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, RPG Life Sciences could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for RPG Life Sciences's Cash-to-Debt or its related term are showing as below:

NSE:RPGLIFE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.59 Max: 11480
Current: No Debt

During the past 13 years, RPG Life Sciences's highest Cash to Debt Ratio was 11480.00. The lowest was 0.01. And the median was 0.59.

NSE:RPGLIFE's Cash-to-Debt is ranked better than
99.71% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 0.94 vs NSE:RPGLIFE: No Debt

RPG Life Sciences Cash-to-Debt Historical Data

The historical data trend for RPG Life Sciences's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

RPG Life Sciences Cash-to-Debt Chart

RPG Life Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

0.06

19.98

74.26

11,480.00

No Debt

RPG Life Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	N/A	No Debt	N/A	No Debt

Competitive Comparison of RPG Life Sciences's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RPG Life Sciences's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's Cash-to-Debt falls into.

RPG Life Sciences Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

RPG Life Sciences's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

RPG Life Sciences had no debt ⁽¹⁾.

RPG Life Sciences's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

RPG Life Sciences had no debt ⁽¹⁾.

RPG Life Sciences (NSE:RPGLIFE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

RPG Life Sciences Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

RPG Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (NSE:RPGLIFE) » Definitions » Cash-to-Debt

Traded in Other Exchanges

532983:India

Address

463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030

Website

https://www.rpglifesciences.com

RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines

RPG Life Sciences (NSE:RPGLIFE) Cash-to-Debt : No Debt (1) (As of Sep. 2024)